CSIMarket
 


Painreform Ltd  (PRFX)
Other Ticker:  
 
 

PRFX's Capital Expenditures Growth by Quarter and Year

Painreform Ltd's Capital Expenditures results by quarter and year




PRFX Capital Expenditures (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December 0.01 0.05 0.00 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.01 0.05 0.00 0.00



PRFX Capital Expenditures fourth quarter 2022 Y/Y Growth Comment
Painreform Ltd reported drop in Capital Expenditures in the fourth quarter 2022 by -88% to $ 0.01 millions, from the same quarter in 2021.
This represents worst decline in recent Company history.

Looking into fourth quarter 2022 results within Major Pharmaceutical Preparations industry 260 other companies have achieved higher Capital Expenditures growth. While Painreform Ltd' s Capital Expenditures meltdown of -88% ranks overall at the positon no. 3329 in the fourth quarter 2022.




PRFX Capital Expenditures ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December -88 % - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -88 % - - -

Financial Statements
Painreform Ltd's fourth quarter 2022 Capital Expenditures $ 0.01 millions PRFX's Income Statement
Painreform Ltd's fourth quarter 2021 Capital Expenditures $ 0.05 millions Quarterly PRFX's Income Statement
New: More PRFX's historic Capital Expenditures Growth >>


PRFX Capital Expenditures (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -88 % - - -




Capital Expenditures fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #261
Healthcare Sector #620
Overall #3329

Capital Expenditures Y/Y Growth Statistics
High Average Low
-88 % -88 % -88 %
(Dec 31 2022)  
Capital Expenditures fourth quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #261
Healthcare Sector #620
Overall #3329
Capital Expenditures Y/Y Growth Statistics
High Average Low
-88 % -88 % -88 %
(Dec 31 2022)  

Capital Expenditures by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Painreform Ltd's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRFX's IV. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PRFX's IV. Quarter Q/Q Capital Expenditures Comment


Painreform Ltd's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
0
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.05
Y / Y Capital Expenditures Growth (TTM) - - - - 0 %
Year on Year Capital Expenditures Growth Overall Ranking # # # #